IGF-signaling pathway: GPC3 has been shown to interact with IGF-II and IGF1R and enhance the phosphorylation and activation of IGF1R in HCC cells, thereby triggering the downstream ERK cascade [85]. Here, IGF2 is linked to hepatocellular carcinoma.